Crossing the border into Mexico is another strategy
Clinical trials of sodiumglucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 (GLP1) receptor agonists have shown beneficial effects of these agents on kidney outcomes in patients with type 2 diabetes mellitus
Does the package include everything you need, in the right format
Available at: Sanchis-Gomar, F., Neeland, I.J
doi:10.1016/j.cmet.2022.07.013 Giblin K, et al
Results Search results and study characteristics The search retrieved 2798 records, of which 28 RCTs [6, 7, 26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51] with 23,622 participants were included in the systematic review and network meta-analysis (ESM Fig